Optimising Renal Tumour Management Through Artificial Intelligence Modules

The goal of this observational study is to improve the management of people with renal tumour by multimodal artificial intelligence(AI). It will also measure the accuracy of the predictions from AI models. The main questions it aims to answer are: 1. whether the AI module can accurately provide tumor-related information such as Benign or malignant, subtypes, grading, stage, etc. by learning from preoperative CT images. 2. whether the AI module can help clinicians find out the most suitable surgical programme for people with renal tumor. 3. whether the AI module can integrate CT images and pathology slides, offering supplementary prognostic information to improve postoperative survival. Participants who complete a CT(usually Contrast-enhanced CT, CECT) examination and undergo radical or partial nephrectomy will carry out active surveillance and record postoperative survival data for 5 years.

NCT Number	NCT06714916
Lead Sponsor	Shao Pengfei
Conditions	Renal Neoplasms, Pathology, Renal Cell Cancer
Enrollment	2,100 participants
Start Date	2025-01-01
Primary Completion	2028-01-01 (estimated)
Study Completion	2033-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-03-19